198 related articles for article (PubMed ID: 38123866)
1. Breaking down relationship barriers to increase PrEP uptake and adherence among adolescent girls and young women in Kenya: safety and preliminary effectiveness results from a pilot cluster-randomized trial.
Roberts ST; Hartmann M; Minnis AM; Otticha SO; Browne EN; Montgomery ET; Agot K
J Int AIDS Soc; 2023 Dec; 26(12):e26198. PubMed ID: 38123866
[TBL] [Abstract][Full Text] [Related]
2. Feasibility and Acceptability of the Novel Tu'Washindi Intervention to Increase PrEP Use among Adolescent Girls and Young Women in Siaya County, Kenya.
Minnis AM; Agot K; Hartmann M; Otticha S; Montgomery ET; Roberts ST
AIDS Behav; 2024 Jun; ():. PubMed ID: 38836985
[TBL] [Abstract][Full Text] [Related]
3. Intimate partner violence and oral HIV pre-exposure prophylaxis adherence among young African women.
Giovenco D; Pettifor A; Powers KA; Hightow-Weidman L; Pence BW; Celum C; Delany-Moretlwe S; Hosek S; Donnell D; Anderson PL; Mgodi N; Bekker LG
AIDS; 2022 Jul; 36(8):1151-1159. PubMed ID: 35579012
[TBL] [Abstract][Full Text] [Related]
4. Tu'Washindi na PrEP: Working With Young Women and Service Providers to Design an Intervention for PrEP Uptake and Adherence in the Context of Gender-Based Violence.
Hartmann M; Otticha S; Agot K; Minnis AM; Montgomery ET; Roberts ST
AIDS Educ Prev; 2021 Apr; 33(2):103-119. PubMed ID: 33821679
[TBL] [Abstract][Full Text] [Related]
5. Continued attendance in a PrEP program despite low adherence and non-protective drug levels among adolescent girls and young women in Kenya: Results from a prospective cohort study.
Tapsoba JD; Cover J; Obong'o C; Brady M; Cressey TR; Mori K; Okomo G; Kariithi E; Obanda R; Oluoch-Madiang D; Chen YQ; Drain P; Duerr A
PLoS Med; 2022 Sep; 19(9):e1004097. PubMed ID: 36095005
[TBL] [Abstract][Full Text] [Related]
6. Oral pre-exposure prophylaxis preference, uptake, adherence and continuation among adolescent girls and young women in Kampala, Uganda: a prospective cohort study.
Mayanja Y; Kamacooko O; Lunkuse JF; Muturi-Kioi V; Buzibye A; Omali D; Chinyenze K; Kuteesa M; Kaleebu P; Price MA
J Int AIDS Soc; 2022 May; 25(5):e25909. PubMed ID: 35543110
[TBL] [Abstract][Full Text] [Related]
7. Enhancing HIV pre-exposure prophylaxis outcomes among Kenyan adolescent girls and young women with a novel pharmacy-based PrEP delivery platform: protocol for a cluster-randomized controlled trial.
Lagat HK; Pintye J; Harrington E; Houck S; Kwena Z; Lenn M; Mogaka F; Momanyi V; Mugambi M; Nyerere B; Odoyo J; Omollo V; Ortblad KF; Rota G; Sharma M; Bukusi EA
Trials; 2024 Jun; 25(1):394. PubMed ID: 38890744
[TBL] [Abstract][Full Text] [Related]
8. Assessing longitudinal patterns of depressive symptoms and the influence of symptom trajectories on HIV pre-exposure prophylaxis adherence among adolescent girls in the HPTN 082 randomized controlled trial.
Velloza J; Hosek S; Donnell D; Anderson PL; Chirenje M; Mgodi N; Bekker LG; Delany-Moretlwe S; Celum C;
J Int AIDS Soc; 2021 Jun; 24 Suppl 2(Suppl 2):e25731. PubMed ID: 34164929
[TBL] [Abstract][Full Text] [Related]
9. Integrating preexposure prophylaxis delivery in routine family planning clinics: A feasibility programmatic evaluation in Kenya.
Mugwanya KK; Pintye J; Kinuthia J; Abuna F; Lagat H; Begnel ER; Dettinger JC; John-Stewart G; Baeten JM;
PLoS Med; 2019 Sep; 16(9):e1002885. PubMed ID: 31479452
[TBL] [Abstract][Full Text] [Related]
10. Uptake of and adherence to oral pre-exposure prophylaxis among adolescent girls and young women at high risk of HIV-infection in Kampala, Uganda: A qualitative study of experiences, facilitators and barriers.
Kayesu I; Mayanja Y; Nakirijja C; Machira YW; Price M; Seeley J; Siu G
BMC Womens Health; 2022 Nov; 22(1):440. PubMed ID: 36357920
[TBL] [Abstract][Full Text] [Related]
11. PrEP use and HIV seroconversion rates in adolescent girls and young women from Kenya and South Africa: the POWER demonstration project.
Celum CL; Bukusi EA; Bekker LG; Delany-Moretlwe S; Kidoguchi L; Omollo V; Rousseau E; Travill D; Morton JF; Mogaka F; O'Malley G; Barnabee G; van der Straten A; Donnell D; Parikh UM; Kudrick L; Anderson PL; Haberer JE; Wu L; Heffron R; Johnson R; Morrison S; Baeten JM;
J Int AIDS Soc; 2022 Jul; 25(7):e25962. PubMed ID: 35822945
[TBL] [Abstract][Full Text] [Related]
12. Persistence of oral pre-exposure prophylaxis (PrEP) among adolescent girls and young women initiating PrEP for HIV prevention in Kenya.
de Dieu Tapsoba J; Zangeneh SZ; Appelmans E; Pasalar S; Mori K; Peng L; Tao J; Drain P; Okomo G; Bii S; Mukabi J; Zobrist S; Brady M; Obanda R; Madiang DO; Cover J; Duerr A; Chen YQ; Obong'o C
AIDS Care; 2021 Jun; 33(6):712-720. PubMed ID: 32951437
[TBL] [Abstract][Full Text] [Related]
13. Facilitators and barriers to HIV pre-exposure prophylaxis (PrEP) uptake through a community-based intervention strategy among adolescent girls and young women in Seme Sub-County, Kisumu, Kenya.
Jackson-Gibson M; Ezema AU; Orero W; Were I; Ohiomoba RO; Mbullo PO; Hirschhorn LR
BMC Public Health; 2021 Jul; 21(1):1284. PubMed ID: 34210288
[TBL] [Abstract][Full Text] [Related]
14. The Community PrEP Study: a randomized control trial leveraging community-based platforms to improve access and adherence to pre-exposure prophylaxis to prevent HIV among adolescent girls and young women in South Africa-study protocol.
Medina-Marino A; Bezuidenhout D; Hosek S; Barnabas RV; Atujuna M; Bezuidenhout C; Ngwepe P; Peters RPH; Little F; Celum CL; Daniels J; Bekker LG
Trials; 2021 Jul; 22(1):489. PubMed ID: 34311754
[TBL] [Abstract][Full Text] [Related]
15. High Awareness, Yet Low Uptake, of Pre-Exposure Prophylaxis Among Adolescent Girls and Young Women Within Family Planning Clinics in Kenya.
Sila J; Larsen AM; Kinuthia J; Owiti G; Abuna F; Kohler PK; John-Stewart G; Pintye J
AIDS Patient Care STDS; 2020 Aug; 34(8):336-343. PubMed ID: 32757980
[TBL] [Abstract][Full Text] [Related]
16. Standardised patient encounters to improve quality of counselling for pre-exposure prophylaxis (PrEP) in adolescent girls and young women (AGYW) in Kenya: study protocol of a cluster randomised controlled trial.
Larsen A; Wilson KS; Kinuthia J; John-Stewart G; Richardson BA; Pintye J; Abuna F; Lagat H; Owens T; Kohler P
BMJ Open; 2020 Jun; 10(6):e035689. PubMed ID: 32565464
[TBL] [Abstract][Full Text] [Related]
17. Intimate Partner Violence and Self-Reported Pre-exposure Prophylaxis Interruptions Among HIV-Negative Partners in HIV Serodiscordant Couples in Kenya and Uganda.
Cabral A; M Baeten J; Ngure K; Velloza J; Odoyo J; E Haberer J; Celum C; Muwonge T; Asiimwe S; Heffron R;
J Acquir Immune Defic Syndr; 2018 Feb; 77(2):154-159. PubMed ID: 29076883
[TBL] [Abstract][Full Text] [Related]
18. "
Agot K; Hartmann M; Otticha S; Minnis A; Onyango J; Ochillo M; Roberts ST
Afr J AIDS Res; 2022 Oct; 21(3):221-230. PubMed ID: 36102052
[TBL] [Abstract][Full Text] [Related]
19. From policy to practice: uptake of pre-exposure prophylaxis among adolescent girls and young women in United States President's Emergency Plan for AIDS Relief-supported countries, 2017-2020.
Patel P; Sato K; Bhandari N; Kanagasabai U; Schelar E; Cooney C; Eakle R; Klucking S; Toiv N; Saul J;
AIDS; 2022 Jun; 36(Suppl 1):S15-S26. PubMed ID: 35766572
[TBL] [Abstract][Full Text] [Related]
20. HIV pre-exposure prophylaxis for adolescent girls and young women in Africa: from efficacy trials to delivery.
Celum CL; Delany-Moretlwe S; Baeten JM; van der Straten A; Hosek S; Bukusi EA; McConnell M; Barnabas RV; Bekker LG
J Int AIDS Soc; 2019 Jul; 22 Suppl 4(Suppl Suppl 4):e25298. PubMed ID: 31328444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]